Building clinical trials capacity for tuberculosis drugs in high-burden countries

Hdl Handle:
http://hdl.handle.net/10144/30095
Title:
Building clinical trials capacity for tuberculosis drugs in high-burden countries
Authors:
Schluger, N; Karunakara, U; Lienhardt, C; Nyirenda, T E; Chaisson, R
Journal:
PLoS Medicine
Affiliation:
Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University, New York, NY, USA; Campaign for Access to Essential Medicines, Médecins Sans Frontières, Geneva, Switzerland; Clinical Trial Division, International Union Against Tuberculosis and Lung Disease, Paris, France; European and Developing Countries Clinical Trials Partnership, Cape Town, South Africa; Center for TB Research, Johns Hopkins University, Baltimore, MD, USA
Issue Date:
6-Nov-2007
URI:
http://hdl.handle.net/10144/30095
DOI:
10.1371/journal.pmed.0040302
PubMed ID:
17988170
Submitted date:
2008-06-13
Type:
Article
Language:
en
ISSN:
1549-1676
Appears in Collections:
TB

Full metadata record

DC FieldValue Language
dc.contributor.authorSchluger, N-
dc.contributor.authorKarunakara, U-
dc.contributor.authorLienhardt, C-
dc.contributor.authorNyirenda, T E-
dc.contributor.authorChaisson, R-
dc.date.accessioned2008-06-17T11:41:17Z-
dc.date.available2008-06-17T11:41:17Z-
dc.date.issued2007-11-06-
dc.date.submitted2008-06-13-
dc.identifier.citationPLoS Med 2007;4(11):e302en
dc.identifier.issn1549-1676-
dc.identifier.pmid17988170-
dc.identifier.doi10.1371/journal.pmed.0040302-
dc.identifier.urihttp://hdl.handle.net/10144/30095-
dc.language.isoenen
dc.rightsPublished by Public Library of Science, [url]http://medicine.plosjournals.org/[/url] Archived on this site by Open Access permissionen
dc.subject.meshAntitubercular Agentsen
dc.subject.meshClinical Trials as Topicen
dc.subject.meshDrug Therapy, Combinationen
dc.subject.meshHumansen
dc.subject.meshMycobacterium tuberculosisen
dc.subject.meshTuberculosisen
dc.subject.meshTuberculosis, Multidrug-Resistanten
dc.titleBuilding clinical trials capacity for tuberculosis drugs in high-burden countriesen
dc.typeArticleen
dc.contributor.departmentDivision of Pulmonary, Allergy, and Critical Care Medicine, Columbia University, New York, NY, USA; Campaign for Access to Essential Medicines, Médecins Sans Frontières, Geneva, Switzerland; Clinical Trial Division, International Union Against Tuberculosis and Lung Disease, Paris, France; European and Developing Countries Clinical Trials Partnership, Cape Town, South Africa; Center for TB Research, Johns Hopkins University, Baltimore, MD, USAen
dc.identifier.journalPLoS Medicineen

Related articles on PubMed

All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.